The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow
Ingram, W, Lea, N C, Cervera, J, Germing, U, Fenaux, P, Cassinat, B, Kiladjian, J J, Varkonyi, J, Antunovic, P, Westwood, N B, Arno, M J, Mohamedali, A, Gaken, J, Kontou, T, Czepulkowski, B H, Twine, N A, Tamaska, J, Csomer, J, Benedek, S, Gattermann, N, Zipperer, E, Giagounidis, A, Garcia-Casado, Z, Sanz, G, Mufti, G J
Published in Leukemia (01.07.2006)
Published in Leukemia (01.07.2006)
Get full text
Journal Article
Publication
The JAK2 V617F mutation identifies a subgroup of MD5 patients with isolated deletion 5q and a proliferative bone marrow
INGRAM, W, LEA, N. C, ARNO, M. J, MOHAMEDALI, A, GAKEN, J, KONTOU, T, CZEPULKOWSKI, B. H, TWINE, N. A, TAMASKA, J, CSOMER, J, BENEDEK, S, GATTERMANN, N, CERVERA, J, ZIPPERER, E, GIAGOUNIDIS, A, GARCIA-CASADO, Z, SANZ, G, MUFTI, G. J, GERMING, U, FENAUX, P, CASSINAT, B, KILADJIAN, J. J, VARKONYI, J, ANTUNOVIC, P, WESTWOOD, N. B
Published in Leukemia (2006)
Get full text
Published in Leukemia (2006)
Journal Article